MEB-1170
/ Mebias Discovery
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 09, 2025
MEB-1170: New Chemical Entity for the Treatment of Opioid Use Disorder
(CPDD 2025)
- No abstract available
Addiction (Opioid and Alcohol) • Substance Abuse
February 28, 2023
A Study to Assess the Safety of MEB-1170 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Mebias Discovery, Inc
New P1 trial • Pain • CRP
1 to 2
Of
2
Go to page
1